A Cost-effectiveness Study of the Quadrivalent HPV6/11/16/18 Vaccination in a Two-dose Scheme in Girls of 9-11 Years Old Compared to Bivalent HPV 16/18 Vaccination in Ecuador and Challenges for Public Health and Screening
Journal Title: International STD Research & Reviews - Year 2017, Vol 6, Issue 1
Abstract
Aims: Assess the incremental cost-effectiveness of the quadrivalent HPV6/11/16/18 vaccination as administered in a two-dose scheme to girls between 9 and 11 years old, as compared to the bivalent HPV 16/18 vaccination administered in Ecuador, and to estimate the cost-saving of preventing GW while preventing cervical cancer with both vaccines. Study Design: We used a previously developed transmission dynamic mathematical model to evaluate the impact of routine vaccination of 9-11 year-old females. The model assumed coverage of 90% for two doses of HPV6/11/16/18 vaccine at international price rates versus HPV16/18 vaccine and costs for genital warts treatment. Other simulation parameters include: country socio- demographic variables, sexual behavior and screening parameters among Ecuadorian girls. Results: Over a 100-year period, HPV6/11/16/18 vaccination would result in reductions of HPV 6/11-related disease incidence at the population level as follows: genital warts in females (81.3%), genital warts in males (78.9%) and HPV6/11-related CIN1 (79.7%). These results would translate into a reduction of HPV 6/11-related disease cost of between 52% to 56% for genital warts among females, genital warts among males, and HPV6/11-related CIN1. Under the model assumptions, the estimated net cost of vaccination with the HPV6/11/16/18 vaccine from a public health perspective would be close to -USD$256 million. Adjusted to the net present value, this cost-saving represents USD$180,735,849.09 with a present value interest factor of 0.9512. Conclusions: In Ecuador, routine vaccination of 9-11 year old females with a quadrivalent HPV6/11/16/18 vaccine is cost-saving compared to a bivalent HPV 16/18 vaccine, which suggests a significant public health and economic impact.
Authors and Affiliations
Maria Isabel Roldós, Isabel Espinosa, Amit Kulkarni, Matthew Pillsbury, Andrew Pavelyev, Homero A. Monsanto, Diego Guarín, Miguel Cashat-Cruz
Keywords
Related Articles
- EP ID EP305407
- DOI 10.9734/ISRR/2017/35382
- Views 107
- Downloads 0
Disparities in Sexual Activity Indicators among Youth Living in the Slums of Kampala: Comparisons with Representative National and Urban School-Attending Youth
Aims: This study examined the extent to which youth who live on the streets and in the slums of Kampala experience more HIV risky behaviors than representative national and urban school-attending youth. Place and Duratio...
A Cost-effectiveness Study of the Quadrivalent HPV6/11/16/18 Vaccination in a Two-dose Scheme in Girls of 9-11 Years Old Compared to Bivalent HPV 16/18 Vaccination in Ecuador and Challenges for Public Health and Screening
Aims: Assess the incremental cost-effectiveness of the quadrivalent HPV6/11/16/18 vaccination as administered in a two-dose scheme to girls between 9 and 11 years old, as compared to the bivalent HPV 16/18 vaccination ad...
Oncogenic Human Papillomavirus Detection in Penile Lichen Sclerosus: An Update
Aims: Aim of this study was to better address a possible association of human papillomavirus (HPV) infection with penile lichen sclerosus (LS). Study Design: Paraffin-embedded penile biopsies obtained from adult patients...
Risky Sexual Behaviour among University Students
Introduction: Early sexual debut, having multiple sex partners, and non-use of condoms are some of the risky sexual behaviors among young people that makes them vulnerable to many health problems such as sexually transmi...
Correlates of Vulvovaginal Candidiasis among Attendees of a Special Treatment Clinic in Nigeria
Background: Vulvovaginal candidiasis (VVC) is very common with significant morbidity and health expenditure. Many cases are associated with concurrent infections with other sexually transmitted infections and several fac...